• Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;
Zhao Peiquan, Email: zhaopeiquan@126.com
Export PDF Favorites Scan Get Citation

Retinopathy of prematurity (ROP) is a proliferative vascular retinal disease. Cryotherapy, laser photocoagulation, intravitreal injection of anti-vascular endothelial growth factor, scleral buckling surgery and vitrectomy are the main treatments. Treated with cryotherapy or laser photocoagulation or intravitreal injection of anti-vascular endothelial growth factor, patients with a history of ROP have thicker foveas, and the morphology of the fovea and the development of the retinal vessels in the macular area are affected, resulting in abnormal vision development. However, the specific mechanisms by which different treatments of ROP affecting the development of the macula are not yet clear. It still need further study with large samples to verify and explore, whether changes in the levels of intraocular vascular endothelial growth factor changing the process of normal macular development and how the abnormal development of the macula affects visual function.

Citation: Chen Shuangshuang, Zhang Qi, Ren Jianing, Peng Jie, Zhao Peiquan. Recent advances in foveal development after treatment for retinopathy of prematurity. Chinese Journal of Ocular Fundus Diseases, 2021, 37(5): 394-398. doi: 10.3760/cma.j.cn511434-20200114-00016 Copy

  • Previous Article

    神经纤维瘤病1型合并眼动脉缺血一例
  • Next Article

    Advances of tumor necrosis factor-α inhibitor in the treatment of junior idiopathic arthritis associated uveitis